Reductil marketing agreement - AstraZeneca and BASF will jointly market the anti-obesity drug

被引：0
|
作者：
Fox, S
机构：
来源：
GENETIC ENGINEERING NEWS | 1999年 / 19卷 / 17期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：15 / +
页数：1
相关论文
共 50 条
  • [31] Will Tirzepatide Become a Game-Changer Anti-Obesity Drug?
    Kumar, Ashish
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (03) : 532 - 533
  • [32] NPY receptors as potential targets for anti-obesity drug development
    Yulyaningsih, Ernie
    Zhang, Lei
    Herzog, Herbert
    Sainsbury, Amanda
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1170 - 1202
  • [33] Newest anti-obesity drug fails to pass FDA muster
    Ault, A
    LANCET, 1998, 351 (9106): : 885 - 885
  • [34] Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug
    Mashmoul, Maryam
    Azlan, Azrina
    Khaza'ai, Huzwah
    Yusof, Barakatun Nisak Mohd
    Noor, Sabariah Mohd
    ANTIOXIDANTS, 2013, 2 (04) : 293 - 308
  • [35] PYY3-36 as an anti-obesity drug target
    Boggiano, MM
    Chandler, PC
    Oswald, KD
    Rodgers, RJ
    Blundell, JE
    Ishii, Y
    Beattie, AH
    Holch, P
    Allison, DB
    Schindler, M
    Arndt, K
    Rudolf, K
    Mark, M
    Schoelch, C
    Joost, HG
    Klaus, S
    Thöne-Reineke, C
    Benoit, SC
    Seeley, RJ
    Beck-Sickinger, AG
    Koglin, N
    Raun, K
    Madsen, K
    Wulff, BS
    Stidsen, CE
    Birringer, M
    Kreuzer, OJ
    Deng, XY
    Whitcomb, DC
    Halem, H
    Taylor, J
    Dong, J
    Datta, R
    Culler, M
    Ortmann, S
    Castañeda, TR
    Tschöp, M
    OBESITY REVIEWS, 2005, 6 (04) : 307 - 322
  • [36] Targeting thermogenesis and related pathways in anti-obesity drug discovery
    Clapham, John C.
    Arch, Jonathan R. S.
    PHARMACOLOGY & THERAPEUTICS, 2011, 131 (03) : 295 - 308
  • [37] Design, development and optimization of selfmicroemulsifying drug delivery system of an anti-obesity drug
    Jagruti, Desai
    Nirav, Khatri
    Sachin, Chauhan
    Avinash, Seth
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2012, 4 (05): : S21 - S22
  • [38] Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug
    Hirosawa, Keiya
    Fukami, Tatsuki
    Nakano, Masataka
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (08) : 1016 - 1023
  • [39] Safety Assessment of an Anti-Obesity Drug (Sibutramine)A Retrospective Cohort Study
    Jerzy E. Tyczynski
    Denise M. Oleske
    David Klingman
    Cheryl P. Ferrufino
    Won Chan Lee
    Drug Safety, 2012, 35 (8) : 629 - 644
  • [40] Adenylate cyclase 3: a new target for anti-obesity drug development
    Wu, L.
    Shen, C.
    Ahmed, M. Seed
    Ostenson, C. -G.
    Gu, H. F.
    OBESITY REVIEWS, 2016, 17 (09) : 907 - 914
12345